Synthesis and Cytotoxic Activity of (4-Substituted-benzylidene)-(3-Phenyl-1,2,4-Oxadiazol-5-YL)Methylamines


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

This work was aimed at the synthesis and investigation of the cytotoxic activity of a series of Schiff bases having (4-substituted-benzylidene)-(3-phenyl-1,2,4-oxadiazol-5-yl)methylamine structure with different electronic natures of substituents in the phenyl ring. Thus, the study was intended to observe the effect of substituents with different electronic properties on the cytotoxic activity. The synthesized series of compounds (OP) were obtained by six-step synthesis with yields ranging from 12.23 to 25.77%. The chemical structures of these compounds were elucidated by H NMR. The cytotoxicity of compounds against human oral squamous cell carcinoma cell lines [Ca9-22 (gum), HSC-2 (mouth), HSC-3 (fluent), HSC-4 (language)] and human oral normal cells [HGF (gum fibroblasts), HPC (pulp cells), and HPLF (periodontal ligament fibroblasts)] was tested by MTT assay. Among the group of six OP compounds, bromo derivative OP2, non-substituted derivative OP1, and chloro derivative OP3 showed higher cytotoxicity (2.71-, 1.56-, and 1.53-fold, respectively) than the reference compound 5-FU. In addition, OP2 (3.27) exhibited the greatest selectivity index in this group. These compounds can be considered to be model structures for further studies.

Sobre autores

K. Kucukoglu

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University

Autor responsável pela correspondência
Email: kucukogluk35@hotmail.com
Turquia, Erzurum

M. Tugrak

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University

Email: sakagami@dent.meikai.ac.jp
Turquia, Erzurum

A. Demirtas

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University

Email: sakagami@dent.meikai.ac.jp
Turquia, Erzurum

H. Sakagami

Division of Pharmacology, School of Dentistry, Meikai University

Autor responsável pela correspondência
Email: sakagami@dent.meikai.ac.jp
Japão, Sakado, Saitama, 350-0283

H. Gul

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University

Email: sakagami@dent.meikai.ac.jp
Turquia, Erzurum


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies